DNAprint Genomics (DNAG)

[mingwan0]

One final observation on this subject. In the May 2004 10Q the following appears:

NOTE G- CONTINGENCIES

We are involved in certain legal action arising in the ordinary course of business. We are defending these proceedings. While it is not feasible to predict or determine the outcome of this matter, we do not anticipate that this matter will have a material adverse effect on our business or on our consolidated financial position or on our results of operations.

Now, you either believe this or you do not. If you do not then, on the same basis, you probably should not believe anything else in the 10Q (or 10K or any other communication such as a newsletter etc). I choose to believe what I read in black and white in an SEC filing. There is no ambiguity IMO - the company believes that these lawsuits are not material.